Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125283012 | 12528301 | 2 | F | 20160712 | 20160705 | 20160727 | EXP | FR-CONCORDIA PHARMACEUTICALS INC.-CO-KX-FR-2016-015 | CONCORDIA | LARDE J,JACQUES V,GERARDIN A,PERTEK J,LEMELLE J,LOSSER M. COLONIC PERFORATION AFTER ORAL INTAKE OF KAYEXALATE (POLYSTYRENE SULFONATE DE SODIUM).. ANESTH REANIM. 2016 JAN 01;. | 48.00 | YR | F | Y | 0.00000 | 20160727 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125283012 | 12528301 | 1 | PS | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Unknown | U | 11287 | 30 | G | ||||||||
| 125283012 | 12528301 | 2 | SS | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Oral | U | 11287 | 15 | G | QD | |||||||
| 125283012 | 12528301 | 3 | SS | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | Unknown | U | 11287 | ||||||||||
| 125283012 | 12528301 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 125283012 | 12528301 | 5 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | 0 | ||||||||||||
| 125283012 | 12528301 | 6 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 0 | ||||||||||||
| 125283012 | 12528301 | 7 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 125283012 | 12528301 | 8 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | 0 | ||||||||||||
| 125283012 | 12528301 | 9 | C | DARBEPOETIN ALFA | DARBEPOETIN ALFA | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125283012 | 12528301 | 1 | Hyperkalaemia |
| 125283012 | 12528301 | 4 | Immunosuppressant drug therapy |
| 125283012 | 12528301 | 5 | Immunosuppressant drug therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125283012 | 12528301 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125283012 | 12528301 | Ascites | |
| 125283012 | 12528301 | Enterococcal infection | |
| 125283012 | 12528301 | Escherichia infection | |
| 125283012 | 12528301 | Gastrointestinal necrosis | |
| 125283012 | 12528301 | Ischaemic ulcer | |
| 125283012 | 12528301 | Large intestine perforation | |
| 125283012 | 12528301 | Multiple organ dysfunction syndrome | |
| 125283012 | 12528301 | Peritonitis | |
| 125283012 | 12528301 | Septic shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |